• DOI:10.1159/000324533
Corpus ID: 11873791

Excess Sudden Cardiac Deaths after Short-Term Clarithromycin Administration in the CLARICOR Trial: Why Is This So, and Why Are Statins Protective?

@article{Winkel2011ExcessSC,
  title={Excess Sudden Cardiac Deaths after Short-Term Clarithromycin Administration in the CLARICOR Trial: Why Is This So, and Why Are Statins Protective?},
  author={P. Winkel and J. Hilden and J. Fischer Hansen and P. Hildebrandt and J. Kastrup and H. J. Kolmos and E. Kj{\o}ller and C. Jespersen and C. Gluud and G. Jensen},
  journal={Cardiology},
  year={2011},
  volume={118},
  pages={63 - 67}
}

• P. Winkel, J. Hilden, +7 authors G. Jensen
• Published 2011
• Medicine
• Cardiology

Objectives: To elucidate potential mechanisms for the clarithromycin-induced excess mortality observed in the CLARICOR trial during 2.6 year follow-up of patients with stable coronary artery disease. Methods: Cox analyses using out-of-hospital death as a proxy for sudden death compared to in-hospital (nonsudden) death. Result: In 100 of 189 (53%) cardiovascular (CV) deaths in which it was possible to examine the question, there was a strong association between place of death and the… Expand

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed